Fundamental's first campaign is aimed at funding the research of 4 specific studies

The science

people around the world are suffering from mental health issues.

450 million

At Fundamental we do not support or foment use of psychedelics or any other types of drugs for recreational use. 

The purpose of this initiative is to garner funds and support exclusively for rigorous scientific research of psychedelics for therapeutic purposes and other applications. The studies yield results relating to the use of psychedelic compounds exclusively under controlled environments and under the supervision of trained professionals. Under no circumstances should anyone prone to or suffering from schizophrenia and/or bipolar disorder intake any psychedelic compounds.

One in four Americans currently struggle with mental health, leading to over USD $400 billion in lost earnings and health care costs each year. About two thirds of those diagnosed never seek treatment.

people struggle with mental health

60 million

In the US alone,

Prevalence of mental illness in the U.S. by diagnosis* 

42 Million Adults 

16 Million Adults 

17 Million Adults 

*Based on 2015 reports by the National Alliance on Mental Illness and 2012 reports by the National Institute on Alcohol Abuse and Alcoholism

Anxiety Disorders

Major Depression

Alcohol Abuse Disorder

It's time.

Spark a mental health revolution in the name of someone you love.

The mystical experience is composed of six main parts

According to Dr. Walter Pahnke and Dr. William Richards:

Since traditional sources of funding are limited, Fundamental is crowdfunding to support scientific research for the application of psychedelic compounds as therapeutic treatments.

© Copyright 2017 Fundamental

Testimonial: The experience did not restore him to his former life, he said, “but I have a greater sense of peace of what might come. I’m very grateful, beyond words, for this trial. But you have to approach the session with the right intentions of why you’re doing it. Because you’re going to meet yourself. ”

Mystical-type experiences induced by psychedelics predict long term positive changes in attitudes, mood, behavior and spirituality in patients.

Ineffability and Paradoxicality

Internal Unity

Trascendence of Time and Space

Deeply-Felt Positive Mood

Sense of Sacredness

A sense that the experience cannot be described adequately in words. An experience of a paradoxical awareness that two apparently opposite principles or situations are both true.

Freedom from the limitations of one’s personal self and feeling a unity or bond with what was felt to be greater than one’s personal self. An experience of the insight that “all is One.”

A feeling that the consciousness experienced during part of the session was more real than one’s normal awareness of everyday reality; realizing a truth that is greater than the truth.

A feeling that one experienced something profoundly sacred and holy; a sense of awe or awesomeness; a sense of the limitations and smallness of one’s everyday personality in contrast to the Infinite.

An experience of overflowing energy, feelings of peace and tranquility, universal or infinite love,  and absolute ecstasy.

A feeling of experiencing eternity or infinity; a loss of the usual sense of time and space; a feeling that one has been outside of history in a realm where time does not exist.

3.

4.

5.

6.

Noetic Quality

1.

2.

How it works

Individuals and institutions make tax-deductible donations via CrowdRise.com, and can choose which of the four studies to allocate the contributions

All funds go into a Donor Advised Fund, held at Charities Aid Foundation of America (CAFA), to ensure transparency and security.


1.

2.

3.

Once the campaign ends, CAFA grants the funds to the institutions with the exclusive purpose of supporting the research.

End-of-Life Distress research

Alcoholism research

PTSD research

Micro-dosing research

Now suppose you could be a part of it. That it is in your hands to spark a mental health revolution in the name of someone you love.

You would contribute in any way you could, wouldn’t you?

The mental health crisis

The Fundamental approach

SIGN UP TO LEARN MORE

FUND A MENTAL HEALTH REVOLUTION

in the name of someone you love.

Dr. Stephen Ross

NYU School of Medicine, Lead Researcher in psilocybin treatment for end-of-life distress in patients with life-threatening cancer

Dr. Michael Bogenschutz

NYU School of Medicine, Leading Researcher in psilocybin treatments for addiction

Multidisciplinary Association for Psychedelic Studies (MAPS), Founder & Executive Director; Lead Researcher in MDMA treatment in PTSD patients

Dr. Rick Doblin


The scientific research is led by:



Meet The Team

The Beckley Foundation, Founder & director
Imperial Research Programme, Co-director, leading research in Microdosing with LSD focused on cognition & creativity

Amanda Feilding

End-of-life anxiety

Research on:

With psilocybin-assisted psychotherapy

Dr. Stephen Ross - MD

NYU School of Medicine

Research led by:

The Issue 

Around 40-50% of newly-diagnosed cancer patients suffer some sort of depression or anxiety. Antidepressants have little effect, particularly on the “existential” depression that can lead some to feel their lives are meaningless, and to contemplate suicide.



The Research

Psilocybin produced significant decreases in clinician-rated and self-rated measures of depression, anxiety and mood disturbance, and increases in quality of life, death acceptance and optimism; effects sustained for at least six months.



The Future 

A larger study with a more diverse population should be conducted to establish the generality and safety of psilocybin treatment of psychological distress associated with life-threatening cancer.


End-of-life Anxiety


Alcoholism


PTSD


Brain Cognition

Participate in the Fundamental crowdfunding campaign and support the groundbreaking research that leading scientists are doing to treat end-of-life anxiety, addiction, PTSD and brain cognition with psychedelic assisted therapies.

Together we can fund a mental health revolution

Alcoholism

Research on:

Dr. Michael Bogenschutz MD

NYU School of Medicine

Research led by:

With psilocybin-assisted psychotherapy

The Issue

Addiction to alcohol, tobacco, and other drugs is the leading preventable cause of death and disability globally; the economic costs of substance use disorders are over half a trillion dollars per year in the US alone, including factors like health care costs, lost productivity, crime, and law enforcement.



The Research 

The psychedelic method, rather than emphasizing resolution of childhood conflicts or traumatic experiences, used higher doses of hallucinogens. Administered on one or a few occasions with the goal of inducing a “mystical” experience, they often induced lasting change in habitual patterns of thought, emotional response, and behavior.



The Future

Randomized-controlled trials are now in progress testing the efficacy of psilocybin-assisted treatment of various substance use disorders, and more will likely be needed.

(Post Traumatic Stress Disorder)

Research on:

With MDMA-assisted psychotherapy

PTSD

Research led by:

Dr. Rick Doblin PhD

Multidisciplinary Association for Psychedelic Studies (M.A.P.S)

The Issue

PTSD is a debilitating anxiety disorder characterized by re-experiencing, hyperarousal and avoidance symptoms. In the US, the lifetime prevalence of PTSD in the general population is between 6% and 10%. Existing therapies for PTSD are ineffective for 25-50% of patients in clinical trials.



The Research

Preliminary studies have shown that MDMA, in conjunction with psychotherapy, can help people overcome PTSD, and possibly other disorders as well. MDMA is known for increasing feelings of trust and compassion towards others, which could make an ideal adjunct to psychotherapy for PTSD.



The Future 

More studies are needed to finalize the methodology, assess the magnitude and variance of the treatment’s effect, evaluate whether the method is generalizable across patient populations and different cultures, and address questions about the therapeutic method’s mechanism of action, optimal dosing and possible refinements.

Cognition & creativity

With LSD-microdosing therapies

Research on:

Amanda Feilding

The Beckley Foundation  - The Imperial Research Programme

Research led by:

The Issue 

In the last few years, the world has been waking up to the power of psychedelic micro-dosing, with a particular focus on LSD. Extensive anecdotal reports suggest that micro-dosing can improve mood, enhance cognition, increase productivity, and boost creativity.



The Research

So far, no scientific research has been done to confirm these effects.



The Future

The world’s first scientific study on the efficacy of micro-dosing, using the latest brain imaging technology, a range of validated tests and questionnaires, and will incorporate a new challenge: playing the ancient game of Go.

CONTRIBUTECONTRIBUTE

It's time.

Donate to this research

For more news on these scientific breakthroughs Follow us on Facebook and Twitter 

Current available solutions typically involve a combination of psychotherapy and pharmacotherapy. The effects vary from individual to individual, making it very difficult to gage what the current treatments actually do for patients. Until now, mental health has largely been managed through traditional treatment methods, which in many cases come with a raft of problems: treatments are expensive, bear unpleasant side effects, vary in their consistency, offer no specific completion date, and only treat the symptoms of these illnesses as opposed to the root cause.




Because the substances used in psychedelic-assisted treatments are in the public domain, the compounds can not be patented. Additionally, since these treatments offer long lasting effects on patients, the model goes against traditional treatments that offer high profit from recurrent medication. 

With no help from the government or pharmaceutical companies, these clinical trials must rely solely on the support of a private donors and institutions in order to complete the process toward medicalization and re-scheduling of the compounds.

We live in a society that values making a profit above our own individual and collective mental health. We have the opportunity to do something about it. 

Together we can support something that will make a legitimate and significant positive impactful on society.

The scientists

Donate to this researchDonate to this researchDonate to this researchCONTACT US

The Mental Health Revolution

Why we do this

Facebook
Twitter

Sign up for updates

Sign up for updates

What the media is saying